Could Lab-Grown nerve cells help paralyzed patients move again?
NCT ID NCT06974968
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new stem cell therapy called XS228 for people with recent spinal cord injuries. The treatment uses lab-made nerve cells injected into the spinal fluid to help repair damage. About 60 adults with incomplete paralysis will receive either XS228 or a placebo and be followed for one year. The goal is to see if the therapy safely improves movement, sensation, and bladder/bowel control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL TRIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510630, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 'Smart Bridge' in the spine help paralyzed patients walk again?
- Spinal zaps may steady blood pressure in spinal cord injury
- Can a simple pill stabilize blood pressure after spinal cord injury?
- Can breathing power boost balance and Well-Being in paralympic athletes?
- Spinal implant + robot rehab: a new hope for walking after injury?
- Can a robotic suit plus spinal stimulation help paralyzed individuals walk again?